The estimated Net Worth of Jane E Md Henney is at least $6.97 Million dollars as of 5 March 2023. Jane Henney owns over 2,300 units of Amerisource Bergen stock worth over $4,442,806 and over the last 21 years he sold ABC stock worth over $2,198,892. In addition, he makes $332,582 as Lead Independent Director at Amerisource Bergen.
Jane has made over 51 trades of the Amerisource Bergen stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 2,300 units of ABC stock worth $413,954 on 5 March 2023.
The largest trade he's ever made was exercising 36,890 units of Amerisource Bergen stock on 24 March 2011 worth over $890,525. On average, Jane trades about 1,417 units every 41 days since 2004. As of 5 March 2023 he still owns at least 24,685 units of Amerisource Bergen stock.
You can see the complete history of Jane Henney stock trades at the bottom of the page.
Dr. Jane E. Henney M.D. serves as Lead Independent Director of the Company. She has served as Home Secretary for the National Academy of Medicine since April 1, 2014. Dr. Henney was a Professor of Medicine at the College of Medicine at the University of Cincinnati from January 2008 until December 2012. She served as Senior Vice President and Provost for Health Affairs at the University of Cincinnati from July 2003 to January 2008 and was the Commissioner of Food and Drugs at the United States Food and Drug Administration from 1998 to 2001. Dr. Henney served as Vice President for Health Sciences at the University of New Mexico from 1994 to 1998. Dr. Henney previously served as a director of CIGNA Corporation from April 2004 until April 2018, AstraZeneca PLC from September 2001 to April 2011, Cubist Pharmaceuticals, Inc. from March 2012 to January 2014 and The China Medical Board from July 2004 until June 2019. Dr. Henney is a National Association of Corporate Directors (NACD) Board Leadership Fellow. Dr. Henney is a former member of the Board of The Commonwealth Fund and The Monnell Center for the Chemical Senses.
As the Lead Independent Director of Amerisource Bergen, the total compensation of Jane Henney at Amerisource Bergen is $332,582. There are 10 executives at Amerisource Bergen getting paid more, with Steven Collis having the highest compensation of $11,309,900.
Jane Henney is 72, he's been the Lead Independent Director of Amerisource Bergen since 2016. There are no older and 24 younger executives at Amerisource Bergen.
Jane's mailing address filed with the SEC is 1 WEST FIRST AVENUE, , CONSHOHOCKEN, PA, 19428.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg, and Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: